Selective IgA Deficiency
What is Selective IgA Deficiency?
Selective IgA deficiency is the most common primary immunodeficiency disorder, affecting approximately 1 in 500 people in populations of European descent. It occurs when the body produces little to no immunoglobulin A (IgA) antibodies while maintaining normal levels of other antibody types (IgG and IgM). IgA antibodies play a crucial role in protecting mucous membranes lining the respiratory and digestive tracts, so people with IgA deficiency may have increased susceptibility to infections in these areas.
The condition is defined by serum IgA levels below 7 mg/dL (normal adult range is 70-400 mg/dL) with normal IgG and IgM levels and normal immune cell function. Most people with selective IgA deficiency have levels below 5 mg/dL or completely undetectable IgA.
Symptoms and Clinical Presentation
Many people with selective IgA deficiency have no symptoms at all and are only diagnosed incidentally during blood work for other reasons. When symptoms do occur, they typically include:
Recurrent infections: Sinusitis, ear infections, bronchitis, pneumonia, and gastrointestinal infections are more common. However, many people with IgA deficiency never experience frequent infections.
Allergic conditions: Asthma, allergic rhinitis (hay fever), eczema, and food allergies occur more frequently in people with IgA deficiency compared to the general population.
Autoimmune diseases: There's an increased risk of developing autoimmune conditions, particularly celiac disease (10-20 times higher risk), rheumatoid arthritis, systemic lupus erythematosus (SLE), and autoimmune thyroid disease.
Gastrointestinal problems: Chronic diarrhea, inflammatory bowel disease, and malabsorption can occur, sometimes related to coexisting celiac disease or other digestive conditions.
Causes and Risk Factors
The exact cause of selective IgA deficiency isn't fully understood, but several factors contribute:
Genetic factors: The condition often runs in families, suggesting genetic predisposition. It's associated with certain HLA gene variants, particularly those also linked to celiac disease and other autoimmune conditions. Some cases are inherited in an autosomal dominant or recessive pattern.
Immune system maturation: IgA deficiency is common in young children and often resolves as the immune system matures. Persistent deficiency into adulthood suggests a permanent condition.
Medications: Certain drugs, including some anti-seizure medications (phenytoin) and immunosuppressants, can cause temporary IgA deficiency that typically resolves when the medication is stopped.
Chromosomal abnormalities: Deletion of chromosome 18 is associated with IgA deficiency.
Diagnosis
Selective IgA deficiency is diagnosed through blood testing that measures immunoglobulin levels:
Serum IgA measurement: The primary diagnostic test shows IgA below 7 mg/dL or undetectable.
Other immunoglobulin levels: IgG and IgM must be normal or elevated for the diagnosis of selective IgA deficiency. If multiple immunoglobulin types are low, it suggests a different immunodeficiency disorder called common variable immunodeficiency (CVID).
Age consideration: Children under age 4 shouldn't be diagnosed with selective IgA deficiency because IgA levels normally mature through early childhood. The diagnosis is usually made after age 4 when IgA levels should have reached normal adult ranges.
Important Clinical Implications
Celiac disease testing: This is critically important. Standard celiac disease screening uses tTG IgA (tissue transglutaminase IgA antibodies), which will be falsely negative in people with IgA deficiency regardless of whether they have celiac disease. Anyone with IgA deficiency being evaluated for celiac disease must have alternative testing with tTG IgG and/or deamidated gliadin peptide (DGP) antibodies. Given the 10-20 times higher risk of celiac disease in people with IgA deficiency, screening should be considered even without obvious symptoms.
Blood transfusion precautions: Some people with IgA deficiency (particularly those with complete absence of IgA) develop antibodies against IgA. If they receive blood products containing IgA from donors, they can experience severe allergic reactions or even life-threatening anaphylaxis. People with IgA deficiency should receive blood products from IgA-deficient donors when possible, or washed red blood cells that have had plasma (which contains IgA) removed. All people with IgA deficiency should inform healthcare providers of this condition before any blood transfusion.
Vaccination responses: Most vaccines work normally in people with selective IgA deficiency because they rely on IgG antibodies, which are normal in this condition. However, mucosal immunity (protection at mucous membrane surfaces) may be reduced.
Treatment and Management
There is no cure for selective IgA deficiency and no way to replace the missing IgA antibodies. Management focuses on monitoring and treating complications:
Infection management: Most people with IgA deficiency don't need preventive antibiotics. For those with frequent respiratory or sinus infections, some doctors prescribe prophylactic antibiotics during high-risk periods (winter months, after known exposure). Prompt treatment of infections when they occur is important to prevent complications.
Allergy treatment: Standard allergy management with antihistamines, nasal corticosteroids, or immunotherapy (allergy shots) as appropriate.
Autoimmune disease screening: Regular monitoring for celiac disease (using IgG-based tests), autoimmune thyroid disease, and other autoimmune conditions, especially if symptoms develop.
Immunoglobulin replacement: Unlike other immunodeficiency disorders, IVIG (intravenous immunoglobulin) is not beneficial for selective IgA deficiency because commercial IVIG preparations don't contain functional IgA and may even be dangerous due to risk of allergic reactions in people with anti-IgA antibodies.
Lifestyle measures: Good hand hygiene, avoiding known sick contacts when possible, adequate nutrition, and staying up-to-date on vaccinations all help minimize infection risk.
Prognosis and Long-Term Outlook
The prognosis for selective IgA deficiency is generally excellent:
Many people remain asymptomatic: A significant percentage of people with IgA deficiency never experience health problems related to the condition and live completely normal lives.
Variable course: Some people have frequent infections in childhood that decrease with age, while others develop symptoms only in adulthood. A small percentage experience worsening immune function over time.
Risk of progression: About 10-20% of people with selective IgA deficiency may progress to common variable immunodeficiency (CVID) over their lifetime, a more serious condition where other immunoglobulin levels also become deficient. This typically happens gradually and is monitored through periodic blood tests.
Autoimmune associations: While the risk of autoimmune diseases is increased, most people with IgA deficiency don't develop these conditions. However, awareness and monitoring are important for early detection.
Life expectancy: For the majority of people with selective IgA deficiency who don't develop serious complications, life expectancy is normal.
Special Considerations
Pregnancy: Women with IgA deficiency can have normal pregnancies, though the increased risk of infections should be monitored. There's a small risk of anti-IgA antibodies causing complications if blood transfusion is needed during delivery.
Surgery: Inform surgeons and anesthesiologists about IgA deficiency before any surgical procedure due to potential blood transfusion needs.
Medical alert: Consider wearing medical alert identification noting IgA deficiency, particularly if you have anti-IgA antibodies, to ensure appropriate blood products are used in emergency situations.
Family screening: First-degree relatives (parents, siblings, children) of someone with IgA deficiency have higher rates of the condition and may benefit from screening, especially if they have recurrent infections or autoimmune symptoms.
Show more